Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis

V Priya, MK Viswanadh, AK Mehata, D Jain… - …, 2021 - Future Medicine
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …

Targeted Nanotherapeutics in The Prophylaxis and Treatment of Thrombosis

V Priya, MK Viswanadh, AK Mehata, D Jain… - …, 2021 - Taylor & Francis
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …

Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis

V Priya, MK Viswanadh, AK Mehata… - Nanomedicine …, 2021 - pubmed.ncbi.nlm.nih.gov
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …

Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis.

V Priya, MK Viswanadh, AK Mehata, D Jain… - Nanomedicine …, 2021 - europepmc.org
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …

[PDF][PDF] Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis

V Priya, MK Viswanadh, AK Mehata, D Jain, SK Singh… - 2021 - researchgate.net
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …

[PDF][PDF] Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis

V Priya, MK Viswanadh, AK Mehata, D Jain, SK Singh… - 2021 - researchgate.net
Currently available anti-thrombotic therapy for the prophylaxis and treatment of arterial and
venous thrombosis includes intravenous administration of anti-thrombotic drugs which lead …